World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01390831
Date of registration: 06/07/2011
Prospective Registration: Yes
Primary sponsor: The Second People's Hospital of Chengdu
Public title: Renal Denervation in Patients With Uncontrolled Hypertension in Chinese
Scientific title: Renal Denervation in Patients With Uncontrolled Hypertension in Chinese
Date of first enrolment: November 2011
Target sample size: 100
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT01390831
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 1/Phase 2
Countries of recruitment
Contacts
Name:     Jian Xiong Liu, MD
Address: 
Telephone: 862886621522-5205
Email: steven.ljx@163.com
Affiliation: 
Name:     Jian Xiong Liu
Address: 
Telephone:
Email:
Affiliation:  The Second People's Hospital of Chengdu
Key inclusion & exclusion criteria

Inclusion Criteria:

- >= 18 years of age

- a systolic blood pressure of 160mmHg or more and/or a diastolic blood pressure of
90mmHg or more

- receiving and adhering to at least three full doses of appropriate antihypertensive
drug regimen

- estimated glomerular filtration rate (eGFR) of =45mL/min

- agrees to have the study procedure(s) performed and additional procedures and
evaluations

- is competent and willing to provide written, informed consent to participate in this
clinical study

Exclusion Criteria:

- secondary hypertension

- renal arterial abnormalities

- has experienced MI, unstable angina pectoris, or CVA within 6 months

- has an implantable cardioverter defibrillator (ICD) or pacemaker, or any other
metallic implant which is not compatible with magnetic resonance imaging (MRI)

- requires respiratory support

- patients with sick sinus syndrome

- pregnant woman

- others



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Hypertension
Intervention(s)
Device: THERMOCOOL® Catheter
Primary Outcome(s)
Blood Pressure Reduction [Time Frame: one year]
Secondary Outcome(s)
Secondary ID(s)
2011SZ0118
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history